2INVD Stock Overview

An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally. More details

2INVD fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	2/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 7.2% below our estimate of its fair value

Became profitable this year

Risk Analysis

Shares are highly illiquid

Large one-off items impacting financial results

Does not have a meaningful market cap (€59M)

My Notes

Capture your thoughts, links and company narrative

2invest AG Competitors

Bioventix

AIM:BVXP

UK£167.0m

Genus

LSE:GNS

UK£1.2b

Spero Therapeutics

NasdaqGS:SPRO

US$49.6m

ECO Animal Health Group

AIM:EAH

UK£42.3m

Price History & Performance

Summary of share price highs, lows and changes for 2invest
Historical stock prices
Current Share Price	€8.30
52 Week High	€0
52 Week Low	€0
Beta	0.32
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-62.78%

Recent updates

Shareholder Returns

	2INVD	GB Biotechs	GB Market
7D	0%	9.3%	3.2%
1Y	n/a	-18.6%	10.9%

Return vs Industry: Insufficient data to determine how 2INVD performed against the UK Biotechs industry.

Return vs Market: Insufficient data to determine how 2INVD performed against the UK Market.

Price Volatility

Is 2INVD's price volatile compared to industry and market?
2INVD volatility
2INVD Average Weekly Movement	n/a
Biotechs Industry Average Movement	8.4%
Market Average Movement	4.9%
10% most volatile stocks in GB Market	10.8%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: 2INVD has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 2INVD's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	5	n/a	2invest-ag.com

2invest AG, an investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally. The company was formerly known as 4basebio AG and changed its name to 2invest AG in January 2021. 2invest AG is based in Heidelberg, Germany.

2invest AG Fundamentals Summary

How do 2invest's earnings and revenue compare to its market cap?
2INVD fundamental statistics
Market cap	€59.21m
Earnings (TTM)	€1.58m
Revenue (TTM)	€9.00m

37.5x

P/E Ratio

6.6x

P/S Ratio

Is 2INVD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2INVD income statement (TTM)
Revenue	€9.00m
Cost of Revenue	€0
Gross Profit	€9.00m
Other Expenses	€7.43m
Earnings	€1.58m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	0.27
Gross Margin	100.00%
Net Profit Margin	17.51%
Debt/Equity Ratio	0%

How did 2INVD perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/08/12 14:57
End of Day Share Price	2024/05/15 00:00
Earnings	2023/12/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

2invest AG is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Andrew Murray Darley	Cavendish
Mark Brewer	Cavendish
Christian Orquera	First Berlin Equity Research GmbH

2invest BATS-CHIXE:2INVD Stock Report